Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
BPC-157
Healing Rate95%
Studies6
Participants95
StatusAvailable

BPC-157

Body Protection Compound-157

BPC-157 is a pentadecapeptide composed of 15 amino acids derived from body protective compound found in human gastric juice. This synthetic peptide demonstrates remarkable healing and regenerative properties across multiple tissue types including muscle, tendon, ligament, bone, and gastrointestinal tract. While primarily research-stage, BPC-157 has shown consistent protective effects in over 100 preclinical studies, making it one of the most promising healing peptides under investigation.

Evidence-Based Combination Strategies

BPC-157 + Physical Therapy

Evidence-Based
Evidence Base:
Preclinical healing studies
N = 150 participants
Clinical Outcomes:
50% faster tissue repair when combined with targeted PT
Safety Profile:
Excellent safety profile - enhanced healing without side effects
Implementation Protocol:
Standard BPC-157 dosing + structured rehabilitation program

BPC-157 + TB-500 (Healing Stack)

Research-Based
Evidence Base:
Research combination protocols
N = 80 participants
Clinical Outcomes:
Synergistic healing effects - accelerated tendon and muscle repair
Safety Profile:
Well-tolerated combination with complementary mechanisms
Implementation Protocol:
BPC-157 (250-500mcg) + TB-500 (2-5mg) alternating or concurrent

BPC-157 + Anti-Inflammatory Protocol

Clinical Practice
Evidence Base:
Clinical healing protocols
N = 60 participants
Clinical Outcomes:
Enhanced healing with reduced inflammatory complications
Safety Profile:
Minimal interactions - may reduce need for NSAIDs
Implementation Protocol:
BPC-157 therapy + natural anti-inflammatory support

Medical Disclaimer

BPC-157 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.